This is a Hasson & Wong sponsored post - the #1 Top Ranked Hair Clinic in Canada according to HairSite patient result statistics.
Some findings suggest that Covid patients with pattern baldness or androgenetic alopecia are more likely to be severely impacted by Covid than patients with no signs of hair loss.
In particular, one finding reveals that among male patients who are within the same age group, those suffering from male pattern baldness can be twice as likely to be hospitalized than patients without pattern baldness.
Some researchers hypothesize that sensitivity to the male sex hormone androgen may play a role in how severe Covid symptoms manifest in the patient.
And the key takeaway from all this?
Research is underway to evaluate the possibility of using antiandrogens or androgen receptor blocker as a new treatment for Covid-19; and if you are suffering from androgenetic alopecia, you should take extra measures in protecting yourself from this virus.
Follow articles below to learn more:
Novel biomarker linked to hair loss can determine COVID severity in men:
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign:
#Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Anti-androgen treatment for Covid-19
https://clinicaltrials.gov/ct2/show/record/NCT04446429
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity:
https://onlinelibrary.wiley.com/doi/10.1111/jocd.13443
This is a Hasson & Wong sponsored post - the #1 Top Ranked Hair Clinic in Canada according to HairSite patient result statistics.